Another cohort study of 160 ESCC patients demonstrated that UHRF1 is as an attractive prognostic marker and potential target for cancer therapy as high levels of UHRF1 corresponded to poor survival rate [122]. Here, UHRF1 is linked to esophageal squamous cell carcinoma.